News Headlines Article

FDA approves new skin cancer drug
San Diego Union-Tribune

Late last month, a new drug to treat the most prevalent form of skin cancer was approved by the Food and Drug Administration.

WebMD said the drug Odomzo received approval for treating locally advanced basal cell carcinoma in patients who are not candidates for surgery or radiation, or for patients whose skin cancer returns following surgery or radiation.

According to WebMD, basal cell carcinoma makes up roughly 80 percent of non-melanoma skin cancers.

Commands